Project Grant R01AI187202
Award Date
12/20/24
Completion Date
11/30/29
Dollars Obligated
$658K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $195,894.00 to The Washington University to study the mechanisms contributing to T cell dysregulation in STAT3 gain-of-function (GOF) syndrome. The primary scientific goal is to investigate critical interactions between T and B cells, as well as the development, polarization, and function of these cells, in order to...
This federal Project Grant award of $534,000 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award supports research by The Children's Hospital of Philadelphia (CHOP) to investigate how the location of antigens and the density and half-life of peptide:MHCII complexes on antigen-presenting cells drive CD4+ T cell differentiation and functionality. Specifically, the research aims to 1)...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $639,485 to the University of Alabama at Birmingham (UAB) from March 1, 2025, to February 28, 2030. The funding supports research to elucidate the mechanisms by which activated forms of the signal transducer and activator of transcription (STAT) proteins STAT1 and STAT3 enter the cell nucleus and induce gene expression...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $986,387 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Children's Hospital of Philadelphia (CHOP) to identify cellular proteins associated with adeno-associated virus (AAV) genomes. The project aims to employ a novel proteomics technology to define the cellular factors that interact with AAV genomes, including those of recombinant AAV (rAAV) vectors. This knowledge is...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $781,685 to The Children's Hospital of Philadelphia Research Institute over 5 years starting December 2024. The funding supports research to understand the molecular circuits controlling human T follicular regulatory (Tfr) cell development and how Tfr cell defects contribute to autoimmune and immunodeficiency...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $385,575.00 to the University of California, San Diego (UCSD) to investigate the underlying mechanisms of immune dysregulation and impaired wound healing in inherited STAT4-mediated autoinflammatory disease. The research aims to determine how gain-of-function mutations in the STAT4 gene lead to persistent...
This federal Project Grant award of $658,657, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to understand the biophysical and functional coupling of protein condensates to ordered lipid domains in T-cells. The principal investigator from the University of Virginia will lead this 5-year research project, collaborating with a subrecipient, The Hospital for Sick Children, to...
This federal Project Grant award, titled "TARGETING IMMUNE DYSREGULATED ENDOTYPES IN SEPSIS (TIDES)", is funded by the National Institute of General Medical Sciences (NIGMS) under CFDA 93.859 Biomedical Research and Research Training program. The total award amount is $179,475 and the project period runs from June 1, 2025 to May 31, 2028. The key products and services to be delivered under this grant are research to define and validate molecular subphenotypes that predict severity of...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $729,006 to The Children's Hospital of Philadelphia Research Institute to conduct research on mechanisms used by adenovirus to manipulate host RNA binding proteins (RBPs) and evade cellular defenses. The 5-year project, which began on January 14, 2025, will employ innovative proteomics and imaging technologies to define changes in RNA-protein...
The federal Project Grant award of $857,346.00, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research at the Fred Hutchinson Cancer Center in Seattle, Washington. The goal is to study the balance of activating and inhibitory signals, in the form of cytokines and metabolites, that regulate the effector function of CD8 T cells in healthy and infected human tissues. The research aims...